These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 17128114
1. [What are the etiological medical therapies in amyotrophic lateral sclerosis?]. Dib M. Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114 [Abstract] [Full Text] [Related]
2. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914 [Abstract] [Full Text] [Related]
3. [Riluzole as a treatment for amyotrophic lateral sclerosis]. Borrás-Blasco J, Plaza-Macías I, Navarro-Ruiz A, Perís-Martí J, Antón-Cano A. Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030 [Abstract] [Full Text] [Related]
4. What has changed with riluzole? Meininger V, Lacomblez L, Salachas F. J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404 [Abstract] [Full Text] [Related]
6. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG. Amyotroph Lateral Scler; 2010 May 03; 11(3):259-65. PubMed ID: 19961263 [Abstract] [Full Text] [Related]
7. Drug therapy for amyotrophic lateral sclerosis: Where are we now? Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG. IDrugs; 2003 Feb 03; 6(2):147-53. PubMed ID: 12789618 [Abstract] [Full Text] [Related]
12. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against. Ludolph AC, Riepe MW. Neurology; 1999 Jun 03; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638 [Abstract] [Full Text] [Related]
13. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold. Armon C, Guiloff RJ, Bedlack R. Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep 03; 3(3):109-12. PubMed ID: 12495570 [Abstract] [Full Text] [Related]
15. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis. Gordon PH. Muscle Nerve; 2009 Jun 03; 39(6):858-60. PubMed ID: 19382169 [Abstract] [Full Text] [Related]
16. [Amyotrophic lateral sclerosis: update on etiological treatment]. Ayach L, Curti C, Montana M, Pisano P, Vanelle P. Therapie; 2013 Jun 03; 68(2):93-106. PubMed ID: 23773350 [Abstract] [Full Text] [Related]
17. [Cotreatment of amyotrophic lateral sclerosis patients]. Iwasaki Y, Ikeda K. Rinsho Shinkeigaku; 1999 Dec 03; 39(12):1253-5. PubMed ID: 10791091 [Abstract] [Full Text] [Related]
18. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis]. Moriwaka F, Tashiro K. Rinsho Shinkeigaku; 2000 Dec 03; 40(12):1258-60. PubMed ID: 11464472 [Abstract] [Full Text] [Related]
20. [Interest of a computerized ALS database in the diagnosis and follow-up of patients with ALS]. Couratier P, Druet-Cabanac M, Truong CT, Bernet-Bernady P, Dumas M, Vallat JM, Preux PM. Rev Neurol (Paris); 2000 Apr 03; 156(4):357-63. PubMed ID: 10795012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]